Chinese firm plans ‘first-in-class’ biologics after $325m manufacturing investment 12-Dec-2018 By Ben Hargreaves The second phase of Changzhou Qianhong Bio-pharma manufacturing project sees a further ¥1 billion devoted to increasing tablet and injection production.